OLOPATADINE HYDROCHLORIDE OPHTHALMIC

OLOPATADINE HYDROCHLORIDE OPHTHALMIC was reported 4099 times

OLOPATADINE HYDROCHLORIDE OPHTHALMIC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FEMORAL PULSE ABNORMAL 2 0.1250
1 CORYNEBACTERIUM SEPSIS 3 0.0455
2 TREATMENT FAILURE 1933 0.0233
3 DISORDER OF ORBIT 3 0.0208
4 DUODENAL NEOPLASM 2 0.0204
5 BRACHYCEPHALY 2 0.0198
6 EXPOSURE TO ALLERGEN 5 0.0157
7 PIERRE ROBIN SYNDROME 3 0.0140
8 EYELID INFECTION 6 0.0136
9 URTICARIAL VASCULITIS 7 0.0133
10 DACRYOCYSTITIS 2 0.0130
11 HUMIDITY INTOLERANCE 5 0.0125
12 AORTIC VALVE THICKENING 2 0.0124
13 PARANASAL CYST 3 0.0123
14 EYELID BLEEDING 2 0.0116
15 KERATOCONUS 4 0.0106
16 THYROIDITIS SUBACUTE 3 0.0103
17 FAMILIAL MEDITERRANEAN FEVER 2 0.0102
18 BLOOD BETA-D-GLUCAN INCREASED 3 0.0098
19 LICHENIFICATION 4 0.0097
20 EMPHYSEMATOUS CYSTITIS 2 0.0094
21 IMMOBILISATION SYNDROME 2 0.0094
22 GOUTY TOPHUS 2 0.0090
23 CENTRAL VISION LOSS 2 0.0090
24 ECZEMA HERPETICUM 4 0.0086
25 CONJUNCTIVITIS ALLERGIC 12 0.0081
26 THROMBOTIC CEREBRAL INFARCTION 3 0.0080
27 SCLERODERMA RENAL CRISIS 3 0.0079
28 VEIN COLLAPSE 6 0.0078
29 CARDIOVASCULAR SYMPTOM 3 0.0077
30 ANTITHROMBIN III DECREASED 2 0.0073
31 MYOFASCIAL PAIN SYNDROME 5 0.0070
32 LIP EROSION 5 0.0068
33 ALOPECIA UNIVERSALIS 2 0.0068
34 HEART FAILURE WITH PRESERVED EJECTION FRACTION 2 0.0068
35 MITRAL VALVE THICKENING 2 0.0067
36 ELECTROCARDIOGRAM QT SHORTENED 2 0.0066
37 ASPERGILLUS TEST POSITIVE 2 0.0065
38 BLOOD PRESSURE SYSTOLIC ABNORMAL 16 0.0065
39 MANUFACTURING ISSUE 3 0.0065
40 PRODUCT DELIVERY MECHANISM ISSUE 34 0.0063
41 ALLERGY TO ARTHROPOD BITE 2 0.0063
42 ADMINISTRATION SITE SWELLING 2 0.0062
43 FACIAL DISCOMFORT 4 0.0056
44 CYTOMEGALOVIRUS ENTEROCOLITIS 4 0.0052
45 UPPER RESPIRATORY TRACT INFLAMMATION 6 0.0050
46 INFUSION SITE DISCHARGE 8 0.0046
47 RENAL COLIC 10 0.0044
48 IMPLANT SITE REACTION 2 0.0044
49 BIOPSY BONE MARROW 2 0.0043
50 PNEUMONIA INFLUENZAL 5 0.0042
51 INFUSION SITE BRUISING 9 0.0042
52 MITRAL VALVE DISEASE 7 0.0040
53 AORTIC VALVE CALCIFICATION 2 0.0039
54 INFUSION SITE PRURITUS 12 0.0038
55 SINUSITIS BACTERIAL 4 0.0038
56 ENCEPHALOMALACIA 2 0.0036
57 CRANIOSYNOSTOSIS 3 0.0035
58 THALAMUS HAEMORRHAGE 3 0.0034
59 DEEP BRAIN STIMULATION 2 0.0033
60 PUNCTATE KERATITIS 3 0.0033
61 CERVICOBRACHIAL SYNDROME 2 0.0033
62 EYE ALLERGY 5 0.0032
63 MITRAL VALVE CALCIFICATION 2 0.0031
64 LIP INJURY 4 0.0031
65 INFUSION SITE HAEMORRHAGE 10 0.0030
66 PRODUCT CLOSURE REMOVAL DIFFICULT 3 0.0029
67 ENTERITIS INFECTIOUS 5 0.0029
68 FULMINANT TYPE 1 DIABETES MELLITUS 3 0.0029
69 BONE MARROW OEDEMA 3 0.0029
70 INFUSION SITE DISCOMFORT 3 0.0029
71 RESPIRATORY TRACT IRRITATION 3 0.0029
72 ALOPECIA AREATA 5 0.0028
73 DEVICE INFUSION ISSUE 7 0.0028
74 CHYLOTHORAX 2 0.0028
75 CHOLANGITIS ACUTE 2 0.0026
76 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 2 0.0026
77 IMMUNE-MEDIATED HEPATIC DISORDER 5 0.0026
78 PYELONEPHRITIS ACUTE 5 0.0025
79 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0025
80 EYELID EXFOLIATION 2 0.0025
81 BRONCHIAL HYPERREACTIVITY 3 0.0025
82 OTITIS EXTERNA 3 0.0025
83 ORAL MUCOSA EROSION 3 0.0024
84 INFUSION SITE ERYTHEMA 20 0.0024
85 TYMPANIC MEMBRANE PERFORATION 4 0.0024
86 MYCOTIC ALLERGY 2 0.0023
87 INFUSION SITE IRRITATION 3 0.0023
88 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
89 PRODUCT PACKAGING DIFFICULT TO OPEN 6 0.0023
90 FOOD REFUSAL 2 0.0023
91 INFUSION SITE DISCOLOURATION 2 0.0023
92 ERYTHEMA MULTIFORME 21 0.0022
93 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
94 INFUSION SITE SWELLING 14 0.0022
95 HYPERPLASIA 2 0.0022
96 INJECTION SITE DRYNESS 2 0.0022
97 HYPERURICAEMIA 9 0.0022
98 RESPIRATORY TRACT INFECTION VIRAL 5 0.0021
99 INJECTION SITE ULCER 2 0.0021
100 INJECTION SITE SCAB 2 0.0021
101 EPIDERMAL NECROSIS 2 0.0021
102 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
103 DRUG ADMINISTERED IN WRONG DEVICE 2 0.0020
104 RHINITIS ALLERGIC 9 0.0020
105 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
106 PEMPHIGOID 15 0.0020
107 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
108 LYMPHOCYTIC INFILTRATION 2 0.0020
109 HYPOGONADISM 2 0.0020
110 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
111 RUBBER SENSITIVITY 3 0.0020
112 CHOLANGITIS 12 0.0019
113 ALLERGY TO ANIMAL 2 0.0019
114 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 2 0.0019
115 SKIN EROSION 6 0.0019
116 IMMUNE-MEDIATED MYOCARDITIS 3 0.0019
117 INFUSION SITE MASS 2 0.0018
118 ARTHROPOD STING 3 0.0018
119 MULTIPLE ALLERGIES 14 0.0018
120 SEASONAL ALLERGY 25 0.0018
121 METABOLIC SURGERY 2 0.0018
122 RESPIRATORY SYMPTOM 5 0.0018
123 GASTROINTESTINAL BACTERIAL INFECTION 2 0.0017
124 ADMINISTRATION SITE PAIN 2 0.0017
125 EYELID DISORDER 4 0.0017
126 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
127 DRUG ERUPTION 30 0.0017
128 INFUSION SITE REACTION 5 0.0017
129 INFECTED CYST 2 0.0017
130 WHITE BLOOD CELLS URINE POSITIVE 3 0.0016
131 SACROILIITIS 3 0.0016
132 CLEFT PALATE 3 0.0016
133 INFUSION SITE PAIN 20 0.0016
134 CONCOMITANT DISEASE PROGRESSION 3 0.0015
135 GASTROENTERITIS NOROVIRUS 2 0.0015
136 INFUSION SITE RASH 2 0.0015
137 BREATH SOUNDS ABNORMAL 7 0.0014
138 TORTICOLLIS 3 0.0014
139 DIABETES MELLITUS NON-INSULIN-DEPENDENT 2 0.0014
140 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
141 LIGAMENT RUPTURE 6 0.0014
142 CONJUNCTIVITIS 25 0.0013
143 EYE DISCHARGE 14 0.0013
144 CHRONIC SINUSITIS 5 0.0013
145 THYROIDITIS 4 0.0013
146 BLOOD PRESSURE SYSTOLIC DECREASED 6 0.0013
147 MARASMUS 2 0.0013
148 FOOD POISONING 7 0.0013
149 BLOOD PRESSURE IMMEASURABLE 2 0.0013
150 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
151 MENOPAUSAL SYMPTOMS 3 0.0013
152 EYE PRURITUS 43 0.0013
153 DYSMORPHISM 3 0.0013
154 SINUS OPERATION 3 0.0013
155 ADRENAL INSUFFICIENCY 15 0.0012
156 MITRAL VALVE PROLAPSE 2 0.0012
157 HEPATORENAL SYNDROME 2 0.0012
158 LAZINESS 2 0.0012
159 BLOOD PH DECREASED 2 0.0012
160 PHYSICAL DECONDITIONING 3 0.0012
161 ACUTE SINUSITIS 2 0.0012
162 EMBOLIC STROKE 4 0.0011
163 GASTROINTESTINAL OEDEMA 2 0.0011
164 JUGULAR VEIN THROMBOSIS 2 0.0011
165 AORTIC VALVE STENOSIS 2 0.0011
166 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
167 VASCULAR DEVICE INFECTION 5 0.0011
168 EAR DISORDER 5 0.0011
169 AMYLASE INCREASED 4 0.0011
170 HEPATIC FUNCTION ABNORMAL 40 0.0011
171 POLYP 7 0.0011
172 EYE INFECTION 12 0.0011
173 MYELOPATHY 2 0.0011
174 FIBULA FRACTURE 3 0.0010
175 HYPERTONIC BLADDER 3 0.0010
176 EYELID MARGIN CRUSTING 3 0.0010
177 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
178 GALLBLADDER INJURY 2 0.0010
179 NASAL SEPTUM DEVIATION 2 0.0010
180 BODY TEMPERATURE DECREASED 10 0.0010
181 OBSTRUCTION 4 0.0010
182 BLOOD PRESSURE FLUCTUATION 24 0.0010
183 MUCOSAL DRYNESS 2 0.0010
184 NEPHROGENIC SYSTEMIC FIBROSIS 3 0.0010
185 INTERNATIONAL NORMALISED RATIO DECREASED 4 0.0010
186 OCULAR DISCOMFORT 11 0.0010
187 RECTAL CANCER 3 0.0010
188 INCREASED UPPER AIRWAY SECRETION 5 0.0010
189 CHOLANGITIS SCLEROSING 2 0.0010
190 EYE IRRITATION 56 0.0010
191 SPINAL COMPRESSION FRACTURE 8 0.0010
192 LUNG ABSCESS 2 0.0010
193 EXOPHTHALMOS 2 0.0009
194 ERYTHEMA OF EYELID 5 0.0009
195 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
196 HYPOGAMMAGLOBULINAEMIA 6 0.0009
197 PARONYCHIA 4 0.0009
198 DANDRUFF 2 0.0009
199 EYE PAIN 51 0.0009
200 CATHETERISATION CARDIAC 4 0.0009
201 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
202 BRONCHIECTASIS 6 0.0009
203 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
204 PHARYNGITIS 11 0.0009
205 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
206 BRAIN OPERATION 2 0.0009
207 HERPES VIRUS INFECTION 5 0.0009
208 NEPHROGENIC ANAEMIA 4 0.0009
209 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
210 GLOSSITIS 3 0.0008
211 SINUS HEADACHE 5 0.0008
212 SKIN WEEPING 3 0.0008
213 EOSINOPHIL COUNT DECREASED 2 0.0008
214 EOSINOPHIL COUNT INCREASED 7 0.0008
215 SINUSITIS 85 0.0008
216 PSEUDOMONAS INFECTION 7 0.0008
217 EYE OEDEMA 2 0.0008
218 LIGAMENT SPRAIN 8 0.0008
219 PULMONARY MASS 12 0.0008
220 HYPERAMMONAEMIA 4 0.0008
221 SWELLING OF EYELID 5 0.0008
222 CORONARY ARTERY STENOSIS 4 0.0008
223 DERMATOMYOSITIS 2 0.0008
224 EAR INFECTION 21 0.0008
225 FOREIGN BODY SENSATION IN EYES 5 0.0008
226 DISSEMINATED TUBERCULOSIS 2 0.0008
227 MENOPAUSE 2 0.0008
228 APHTHOUS ULCER 6 0.0008
229 POOR VENOUS ACCESS 8 0.0008
230 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
231 ORAL INFECTION 3 0.0008
232 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
233 OCULAR HYPERAEMIA 36 0.0008
234 PRODUCTIVE COUGH 36 0.0008
235 OESOPHAGEAL CANDIDIASIS 3 0.0008
236 AZOTAEMIA 3 0.0008
237 HYPERLACTACIDAEMIA 2 0.0007
238 FUNGAL SKIN INFECTION 3 0.0007
239 DRY EYE 37 0.0007
240 ANAPHYLACTOID REACTION 3 0.0007
241 INTERSTITIAL LUNG DISEASE 35 0.0007
242 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
243 VIRAL INFECTION 24 0.0007
244 PNEUMONIA ASPIRATION 18 0.0007
245 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
246 ATYPICAL FEMUR FRACTURE 2 0.0007
247 PERIORBITAL SWELLING 4 0.0007
248 THERMAL BURN 5 0.0007
249 INJECTION SITE SCAR 2 0.0007
250 DERMATITIS CONTACT 8 0.0007
251 DUODENAL ULCER HAEMORRHAGE 2 0.0007
252 ABNORMAL SENSATION IN EYE 3 0.0007
253 SKIN ULCER 18 0.0007
254 EXERCISE TOLERANCE DECREASED 4 0.0007
255 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
256 DIVERTICULITIS 19 0.0007
257 LUMBAR SPINAL STENOSIS 2 0.0007
258 ORAL CANDIDIASIS 9 0.0007
259 CREPITATIONS 2 0.0007
260 GASTROINTESTINAL INFECTION 6 0.0007
261 PROTHROMBIN TIME PROLONGED 4 0.0007
262 ATYPICAL PNEUMONIA 2 0.0007
263 METABOLIC ENCEPHALOPATHY 2 0.0007
264 OROPHARYNGEAL DISCOMFORT 6 0.0007
265 HYPERCAPNIA 2 0.0007
266 BRONCHITIS 49 0.0007
267 MYELOFIBROSIS 2 0.0007
268 HAEMOGLOBIN INCREASED 3 0.0007
269 PNEUMONIA BACTERIAL 6 0.0007
270 INJECTION SITE EXTRAVASATION 8 0.0006
271 MULTIPLE-DRUG RESISTANCE 2 0.0006
272 ROSACEA 3 0.0006
273 BACTERIAL INFECTION 12 0.0006
274 TIBIA FRACTURE 3 0.0006
275 BLOOD CREATININE DECREASED 2 0.0006
276 EOSINOPHILIC PNEUMONIA 2 0.0006
277 FUNGAL INFECTION 21 0.0006
278 MYELODYSPLASTIC SYNDROME 9 0.0006
279 RHINITIS 5 0.0006
280 NEURALGIA 15 0.0006
281 AUTOIMMUNE DISORDER 6 0.0006
282 POST PROCEDURAL INFECTION 5 0.0006
283 BACTERIAL SEPSIS 2 0.0006
284 LYMPHOCYTE COUNT INCREASED 2 0.0006
285 NASAL POLYPS 3 0.0006
286 INJECTION SITE INFECTION 2 0.0006
287 DEAFNESS NEUROSENSORY 2 0.0006
288 STAPHYLOCOCCAL SEPSIS 3 0.0006
289 LISTLESS 2 0.0006
290 ORGANISING PNEUMONIA 3 0.0006
291 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
292 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
293 CHOLECYSTITIS CHRONIC 4 0.0006
294 BREAST MASS 4 0.0006
295 CANDIDA INFECTION 10 0.0006
296 HEPATIC CYST 2 0.0006
297 NEUTROPHIL COUNT DECREASED 24 0.0006
298 PHLEBITIS 3 0.0006
299 MUSCLE STRAIN 5 0.0006
300 GRANULOMA 2 0.0006
301 EAR PRURITUS 2 0.0006
302 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
303 PULMONARY TOXICITY 4 0.0006
304 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
305 BODY HEIGHT DECREASED 6 0.0006
306 HEREDITARY ANGIOEDEMA 6 0.0006
307 SECRETION DISCHARGE 7 0.0006
308 GINGIVITIS 3 0.0006
309 FACIAL BONES FRACTURE 2 0.0006
310 PHARYNGITIS STREPTOCOCCAL 6 0.0006
311 GASTROENTERITIS 8 0.0005
312 BLOOD PHOSPHORUS DECREASED 2 0.0005
313 ASTHMA 61 0.0005
314 PRODUCT DISTRIBUTION ISSUE 5 0.0005
315 HYPERACUSIS 2 0.0005
316 BLOOD CHOLESTEROL INCREASED 25 0.0005
317 IMPULSIVE BEHAVIOUR 2 0.0005
318 TOOTH INFECTION 7 0.0005
319 LACRIMATION INCREASED 16 0.0005
320 SCAB 6 0.0005
321 SINUS CONGESTION 7 0.0005
322 UVEITIS 7 0.0005
323 CELLULITIS 26 0.0005
324 SKIN WARM 3 0.0005
325 EAR PAIN 10 0.0005
326 HYPERTRIGLYCERIDAEMIA 3 0.0005
327 RHINORRHOEA 33 0.0005
328 NASAL DISCOMFORT 4 0.0005
329 PNEUMOTHORAX 8 0.0005
330 DYSPNOEA EXERTIONAL 19 0.0005
331 BLEPHARITIS 2 0.0005
332 CYTOKINE RELEASE SYNDROME 10 0.0005
333 MUSCLE HAEMORRHAGE 2 0.0005
334 TYPE 1 DIABETES MELLITUS 3 0.0005
335 STEVENS-JOHNSON SYNDROME 11 0.0005
336 CEREBRAL INFARCTION 12 0.0005
337 ASPHYXIA 4 0.0005
338 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
339 AORTIC DISSECTION 2 0.0005
340 FEBRILE NEUTROPENIA 32 0.0005
341 INFUSION SITE EXTRAVASATION 3 0.0005
342 DRUG-INDUCED LIVER INJURY 15 0.0005
343 LIVER DISORDER 21 0.0005
344 CARDIAC FAILURE CHRONIC 2 0.0005
345 PRODUCT CONTAINER ISSUE 4 0.0005
346 CARDIAC MURMUR 4 0.0005
347 INSURANCE ISSUE 7 0.0005
348 EYE SWELLING 17 0.0005
349 MELANOCYTIC NAEVUS 2 0.0005
350 LOCALISED INFECTION 11 0.0005
351 TUMOUR LYSIS SYNDROME 4 0.0005
352 MELAENA 10 0.0005
353 RENAL IMPAIRMENT 38 0.0005
354 PRESCRIBED UNDERDOSE 9 0.0005
355 CARDIAC FAILURE ACUTE 3 0.0004
356 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
357 ACUTE MYELOID LEUKAEMIA 7 0.0004
358 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
359 HYPERSENSITIVITY 83 0.0004
360 BRAIN FOG 7 0.0004
361 MENINGITIS ASEPTIC 2 0.0004
362 INTESTINAL PERFORATION 5 0.0004
363 PRODUCT USE COMPLAINT 7 0.0004
364 DEVELOPMENTAL DELAY 4 0.0004
365 NASAL CONGESTION 26 0.0004
366 MITRAL VALVE INCOMPETENCE 5 0.0004
367 RESTLESS LEGS SYNDROME 8 0.0004
368 ECZEMA 23 0.0004
369 INFLUENZA 49 0.0004
370 NEOPLASM 5 0.0004
371 EYE OPERATION 2 0.0004
372 AUTOIMMUNE HEPATITIS 3 0.0004
373 EYELID OEDEMA 5 0.0004
374 HEPATIC STEATOSIS 8 0.0004
375 GASTRITIS EROSIVE 2 0.0004
376 MIDDLE INSOMNIA 8 0.0004
377 APPENDICITIS 4 0.0004
378 DEFAECATION URGENCY 3 0.0004
379 ARTERIOSCLEROSIS 4 0.0004
380 COVID-19 PNEUMONIA 5 0.0004
381 INFUSION RELATED REACTION 28 0.0004
382 RESPIRATORY TRACT INFECTION 11 0.0004
383 GESTATIONAL DIABETES 2 0.0004
384 GUILLAIN-BARRE SYNDROME 2 0.0004
385 FAECES SOFT 3 0.0004
386 C-REACTIVE PROTEIN INCREASED 15 0.0004
387 ORAL HERPES 8 0.0004
388 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
389 SKIN FISSURES 8 0.0004
390 INCORRECT DOSAGE ADMINISTERED 2 0.0004
391 BLOOD PRESSURE DECREASED 27 0.0004
392 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
393 HYPERVOLAEMIA 2 0.0004
394 SINUS DISORDER 8 0.0004
395 DEVICE DEFECTIVE 7 0.0004
396 ILEUS 5 0.0004
397 HERPES ZOSTER 23 0.0004
398 FLUID INTAKE REDUCED 2 0.0004
399 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
400 ANAPHYLACTIC REACTION 22 0.0004
401 ERYSIPELAS 2 0.0004
402 TOXIC SKIN ERUPTION 4 0.0004
403 DRUG TOLERANCE 2 0.0004
404 HEPATOCELLULAR CARCINOMA 3 0.0004
405 TASTE DISORDER 8 0.0004
406 ACIDOSIS 3 0.0004
407 LIPASE INCREASED 3 0.0004
408 EUPHORIC MOOD 4 0.0004
409 INITIAL INSOMNIA 4 0.0004
410 DEVICE RELATED INFECTION 6 0.0004
411 TOOTHACHE 7 0.0004
412 HYPOALBUMINAEMIA 3 0.0004
413 PLATELET COUNT DECREASED 41 0.0004
414 TENDERNESS 4 0.0004
415 GASTROINTESTINAL INFLAMMATION 3 0.0004
416 FOOD CRAVING 2 0.0004
417 GASTRITIS 10 0.0004
418 PULMONARY CONGESTION 5 0.0004
419 BLOOD GLUCOSE ABNORMAL 7 0.0004
420 SARS-COV-2 TEST POSITIVE 5 0.0004
421 ILLNESS 39 0.0004
422 SCIATICA 6 0.0004
423 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
424 COMPRESSION FRACTURE 2 0.0004
425 ANAL FISSURE 2 0.0004
426 PHOTOPHOBIA 7 0.0004
427 ANAL ABSCESS 2 0.0004
428 LIMB INJURY 10 0.0004
429 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
430 SKIN LACERATION 4 0.0004
431 STAPHYLOCOCCAL INFECTION 12 0.0004
432 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
433 EMBOLISM 3 0.0004
434 CYSTIC FIBROSIS 2 0.0004
435 KIDNEY INFECTION 7 0.0004
436 TYPE 2 DIABETES MELLITUS 12 0.0004
437 OXYGEN SATURATION DECREASED 20 0.0004
438 REBOUND EFFECT 4 0.0004
439 CHOLECYSTITIS ACUTE 2 0.0004
440 HYPOPHAGIA 9 0.0004
441 GENERALISED ERYTHEMA 2 0.0004
442 INTENTIONAL DOSE OMISSION 10 0.0004
443 INTERNAL HAEMORRHAGE 4 0.0003
444 NASOPHARYNGITIS 64 0.0003
445 MOUTH SWELLING 2 0.0003
446 ENTEROCOLITIS 2 0.0003
447 HYSTERECTOMY 3 0.0003
448 PRODUCT ADMINISTRATION ERROR 7 0.0003
449 PYELONEPHRITIS 3 0.0003
450 SKIN SWELLING 3 0.0003
451 FEEDING DISORDER 7 0.0003
452 HYPERVENTILATION 2 0.0003
453 HYPOTHYROIDISM 11 0.0003
454 ELECTROLYTE IMBALANCE 4 0.0003
455 HYPOXIA 12 0.0003
456 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
457 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
458 SKIN HAEMORRHAGE 5 0.0003
459 BLOOD IRON DECREASED 4 0.0003
460 ATAXIA 4 0.0003
461 BACTERAEMIA 4 0.0003
462 THIRST 6 0.0003
463 CHOLECYSTITIS 4 0.0003
464 HAEMOLYTIC ANAEMIA 3 0.0003
465 EYE DISORDER 11 0.0003
466 HEPATITIS B 2 0.0003
467 INJECTION SITE VESICLES 2 0.0003
468 BLOOD COUNT ABNORMAL 5 0.0003
469 PRESYNCOPE 8 0.0003
470 INGUINAL HERNIA 2 0.0003
471 DERMATITIS ACNEIFORM 2 0.0003
472 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
473 UROSEPSIS 3 0.0003
474 HYPOKALAEMIA 15 0.0003
475 SPINAL OPERATION 4 0.0003
476 WOUND 9 0.0003
477 DIARRHOEA HAEMORRHAGIC 3 0.0003
478 NASAL DRYNESS 2 0.0003
479 PNEUMONIA 103 0.0003
480 COUGH 89 0.0003
481 FOOT FRACTURE 6 0.0003
482 GASTRIC ULCER 6 0.0003
483 SLEEP APNOEA SYNDROME 6 0.0003
484 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
485 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
486 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
487 ROTATOR CUFF SYNDROME 4 0.0003
488 CARDIAC FAILURE 25 0.0003
489 HAEMOGLOBIN ABNORMAL 2 0.0003
490 URINARY TRACT INFECTION 53 0.0003
491 CARDIAC FLUTTER 2 0.0003
492 INCOHERENT 2 0.0003
493 RASH GENERALISED 8 0.0003
494 INJECTION SITE INDURATION 4 0.0003
495 HAEMORRHOIDS 6 0.0003
496 PRODUCT AVAILABILITY ISSUE 7 0.0003
497 WHEEZING 18 0.0003
498 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
499 RESPIRATORY DISORDER 9 0.0003
500 CYTOMEGALOVIRUS INFECTION 5 0.0003
501 PYREXIA 104 0.0003
502 EYE HAEMORRHAGE 4 0.0003
503 URINARY RETENTION 10 0.0003
504 SEPTIC SHOCK 13 0.0003
505 BLOOD UREA INCREASED 5 0.0003
506 HEPATIC FAILURE 9 0.0003
507 COLITIS ISCHAEMIC 2 0.0003
508 COVID-19 52 0.0003
509 BLOOD BILIRUBIN INCREASED 8 0.0003
510 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
511 OEDEMA 16 0.0003
512 EPISTAXIS 22 0.0003
513 JOINT EFFUSION 2 0.0003
514 HYPERBILIRUBINAEMIA 3 0.0003
515 THERAPY NON-RESPONDER 13 0.0003
516 CARDIAC DISORDER 27 0.0003
517 DELIRIUM 10 0.0003
518 WEIGHT FLUCTUATION 3 0.0003
519 VISION BLURRED 39 0.0003
520 TINNITUS 13 0.0003
521 CYSTITIS 9 0.0003
522 HAND FRACTURE 2 0.0003
523 OROPHARYNGEAL PAIN 26 0.0003
524 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
525 PRODUCT SUBSTITUTION ISSUE 16 0.0003
526 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
527 DERMATITIS BULLOUS 2 0.0003
528 OESOPHAGITIS 3 0.0003
529 ANAPHYLACTIC SHOCK 7 0.0003
530 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
531 FOOT DEFORMITY 3 0.0003
532 LIP SWELLING 9 0.0003
533 ARTHROPOD BITE 2 0.0003
534 RASH MACULO-PAPULAR 6 0.0003
535 DEAFNESS 7 0.0003
536 SKIN INFECTION 3 0.0003
537 INFLUENZA LIKE ILLNESS 22 0.0003
538 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
539 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
540 PROTEINURIA 5 0.0003
541 FEELING JITTERY 5 0.0003
542 BOWEL MOVEMENT IRREGULARITY 2 0.0003
543 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
544 METASTASES TO LUNG 3 0.0003
545 PERICARDIAL EFFUSION 6 0.0003
546 FOOD ALLERGY 2 0.0003
547 ANKLE FRACTURE 4 0.0003
548 CONCUSSION 2 0.0003
549 CAESAREAN SECTION 3 0.0003
550 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
551 THERAPY PARTIAL RESPONDER 4 0.0003
552 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
553 CYANOSIS 4 0.0003
554 LYMPHADENOPATHY 9 0.0003
555 CHEST DISCOMFORT 26 0.0003
556 DEVICE LEAKAGE 11 0.0003
557 FURUNCLE 2 0.0003
558 BLOOD ALBUMIN DECREASED 2 0.0003
559 CATARACT 15 0.0003
560 RESPIRATORY TRACT CONGESTION 4 0.0003
561 MYOCLONUS 3 0.0003
562 ACCIDENT 3 0.0003
563 NECK PAIN 14 0.0003
564 WRIST FRACTURE 3 0.0003
565 WEIGHT INCREASED 56 0.0002
566 MYELOSUPPRESSION 9 0.0002
567 PRODUCT DOSE OMISSION ISSUE 73 0.0002
568 MYASTHENIA GRAVIS 2 0.0002
569 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
570 NOCTURIA 3 0.0002
571 FIBROMYALGIA 6 0.0002
572 DERMATITIS ATOPIC 13 0.0002
573 BACK DISORDER 4 0.0002
574 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
575 CYTOPENIA 3 0.0002
576 LUNG DISORDER 12 0.0002
577 HICCUPS 2 0.0002
578 HYPERAESTHESIA 2 0.0002
579 HEART RATE INCREASED 24 0.0002
580 SEPSIS 27 0.0002
581 CYST 3 0.0002
582 MIGRAINE 23 0.0002
583 HEMIPLEGIA 2 0.0002
584 JOINT SWELLING 29 0.0002
585 INJECTION SITE DISCOLOURATION 3 0.0002
586 BRAIN OEDEMA 3 0.0002
587 FACE OEDEMA 4 0.0002
588 HAEMATEMESIS 6 0.0002
589 ANAEMIA 45 0.0002
590 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
591 HEPATIC ENZYME INCREASED 16 0.0002
592 PRURITUS 90 0.0002
593 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
594 ANURIA 2 0.0002
595 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
596 FAECES DISCOLOURED 5 0.0002
597 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
598 NAIL DISORDER 2 0.0002
599 DECREASED APPETITE 53 0.0002
600 GROIN PAIN 2 0.0002
601 ANKYLOSING SPONDYLITIS 3 0.0002
602 COLD SWEAT 4 0.0002
603 IMMUNOSUPPRESSION 2 0.0002
604 LYMPHOCYTE COUNT DECREASED 4 0.0002
605 HEAD DISCOMFORT 4 0.0002
606 MALAISE 99 0.0002
607 GALLBLADDER DISORDER 4 0.0002
608 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
609 CEREBRAL HAEMORRHAGE 8 0.0002
610 FEAR 6 0.0002
611 JAUNDICE 6 0.0002
612 SNEEZING 5 0.0002
613 PAIN OF SKIN 6 0.0002
614 RASH 97 0.0002
615 ERYTHEMA 45 0.0002
616 OSTEOPOROSIS 9 0.0002
617 PERIPHERAL COLDNESS 3 0.0002
618 HAEMOPTYSIS 6 0.0002
619 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
620 PANCYTOPENIA 12 0.0002
621 HEPATIC ENCEPHALOPATHY 2 0.0002
622 PLEURAL EFFUSION 13 0.0002
623 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
624 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38 0.0002
625 EXPIRED PRODUCT ADMINISTERED 7 0.0002
626 DEHYDRATION 28 0.0002
627 RASH ERYTHEMATOUS 10 0.0002
628 INJECTION SITE PRURITUS 14 0.0002
629 POST PROCEDURAL COMPLICATION 4 0.0002
630 GLAUCOMA 4 0.0002
631 OEDEMA PERIPHERAL 25 0.0002
632 ASCITES 6 0.0002
633 COELIAC DISEASE 2 0.0002
634 ENCEPHALOPATHY 5 0.0002
635 BLADDER DISORDER 2 0.0002
636 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
637 BLOOD PRESSURE ABNORMAL 4 0.0002
638 DRUG INEFFECTIVE 265 0.0002
639 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
640 RASH MACULAR 7 0.0002
641 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
642 DEVICE FAILURE 3 0.0002
643 URTICARIA 33 0.0002
644 DRY THROAT 2 0.0002
645 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
646 DRY SKIN 26 0.0002
647 RIB FRACTURE 4 0.0002
648 LYMPHOMA 3 0.0002
649 DELUSION 3 0.0002
650 RHABDOMYOLYSIS 8 0.0002
651 PRODUCT USE ISSUE 36 0.0002
652 FOLLICULITIS 2 0.0002
653 ARTHRALGIA 79 0.0002
654 MOUTH ULCERATION 4 0.0002
655 SKIN EXFOLIATION 16 0.0002
656 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
657 ULCER 3 0.0002
658 HEADACHE 118 0.0002
659 NO ADVERSE EVENT 34 0.0002
660 CARDIAC FAILURE CONGESTIVE 15 0.0002
661 IRRITABLE BOWEL SYNDROME 4 0.0002
662 INTESTINAL OBSTRUCTION 7 0.0002
663 DECREASED ACTIVITY 2 0.0002
664 LACTIC ACIDOSIS 6 0.0002
665 ATRIAL FIBRILLATION 18 0.0002
666 PALLOR 5 0.0002
667 INJECTION SITE SWELLING 14 0.0002
668 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
669 BACK PAIN 42 0.0002
670 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
671 TACHYCARDIA 16 0.0002
672 PALPITATIONS 21 0.0002
673 WEIGHT DECREASED 50 0.0002
674 CHROMATURIA 4 0.0002
675 DIARRHOEA 114 0.0002
676 BLOOD PRESSURE INCREASED 27 0.0002
677 CIRCULATORY COLLAPSE 3 0.0002
678 MUSCULAR WEAKNESS 20 0.0002
679 IMPAIRED DRIVING ABILITY 2 0.0002
680 HAEMOGLOBIN DECREASED 18 0.0002
681 FEELING ABNORMAL 42 0.0002
682 CHOLECYSTECTOMY 2 0.0002
683 MUSCULOSKELETAL DISCOMFORT 3 0.0002
684 SHOCK 4 0.0002
685 INSOMNIA 46 0.0002
686 HOT FLUSH 13 0.0002
687 MADAROSIS 2 0.0002
688 BLINDNESS 7 0.0002
689 EOSINOPHILIA 3 0.0002
690 HYPERKALAEMIA 6 0.0002
691 SWELLING 16 0.0002
692 SURGERY 10 0.0002
693 SLEEP DISORDER 12 0.0002
694 LABORATORY TEST ABNORMAL 5 0.0002
695 COMA 8 0.0002
696 POLLAKIURIA 7 0.0002
697 MACULAR DEGENERATION 2 0.0002
698 HYPERLIPIDAEMIA 2 0.0002
699 BLOOD POTASSIUM DECREASED 5 0.0002
700 GASTROENTERITIS VIRAL 3 0.0002
701 HYPERTENSION 35 0.0002
702 OSTEOARTHRITIS 7 0.0002
703 CRYING 6 0.0002
704 BURSITIS 2 0.0002
705 RESTLESSNESS 6 0.0002
706 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
707 CARDIOMEGALY 2 0.0002
708 DYSPNOEA 92 0.0002
709 PERIPHERAL SWELLING 25 0.0002
710 INJECTION SITE MASS 6 0.0002
711 GENERALISED OEDEMA 2 0.0002
712 FEMUR FRACTURE 5 0.0002
713 HAIR COLOUR CHANGES 2 0.0002
714 BLISTER 9 0.0002
715 LEUKOPENIA 8 0.0002
716 HEPATIC CIRRHOSIS 3 0.0002
717 PAIN IN EXTREMITY 47 0.0002
718 RHEUMATOID ARTHRITIS 18 0.0002
719 HYPOCALCAEMIA 3 0.0002
720 FRACTURE 3 0.0002
721 BLOOD URINE PRESENT 3 0.0002
722 HEAD INJURY 5 0.0002
723 GASTRIC CANCER 4 0.0002
724 CONDITION AGGRAVATED 48 0.0002
725 INJECTION SITE IRRITATION 2 0.0002
726 BURNING SENSATION 11 0.0002
727 INTRAOCULAR PRESSURE INCREASED 2 0.0002
728 MYDRIASIS 2 0.0002
729 INFLAMMATION 8 0.0002
730 HIATUS HERNIA 2 0.0002
731 DIZZINESS 77 0.0002
732 NEPHROLITHIASIS 7 0.0002
733 ABNORMAL BEHAVIOUR 6 0.0002
734 CONSTIPATION 33 0.0002
735 DYSMENORRHOEA 2 0.0002
736 ADVERSE REACTION 2 0.0002
737 PREGNANCY 3 0.0001
738 PAIN 92 0.0001
739 GAIT INABILITY 5 0.0001
740 HYPOTENSION 30 0.0001
741 HAIR TEXTURE ABNORMAL 2 0.0001
742 PRODUCT USE IN UNAPPROVED INDICATION 37 0.0001
743 PRODUCT PHYSICAL ISSUE 3 0.0001
744 THROAT TIGHTNESS 4 0.0001
745 NAUSEA 117 0.0001
746 MUSCLE SPASMS 27 0.0001
747 HYPOAESTHESIA 22 0.0001
748 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
749 PNEUMONITIS 4 0.0001
750 GINGIVAL BLEEDING 2 0.0001
751 HAEMATURIA 5 0.0001
752 SKIN LESION 4 0.0001
753 INFECTION 21 0.0001
754 PERITONITIS 3 0.0001
755 VOMITING 68 0.0001
756 FALL 48 0.0001
757 PROCEDURAL PAIN 4 0.0001
758 PULMONARY HYPERTENSION 3 0.0001
759 ABDOMINAL DISTENSION 15 0.0001
760 HYPOMAGNESAEMIA 2 0.0001
761 CARDIO-RESPIRATORY ARREST 6 0.0001
762 DEMENTIA 4 0.0001
763 HEART RATE DECREASED 5 0.0001
764 ABDOMINAL PAIN 33 0.0001
765 PAIN IN JAW 4 0.0001
766 GAIT DISTURBANCE 27 0.0001
767 EATING DISORDER 3 0.0001
768 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
769 JOINT INJURY 3 0.0001
770 CHEST PAIN 26 0.0001
771 RED BLOOD CELL COUNT DECREASED 4 0.0001
772 POOR QUALITY SLEEP 3 0.0001
773 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
774 DEEP VEIN THROMBOSIS 9 0.0001
775 BLOOD CREATININE INCREASED 9 0.0001
776 FLUID RETENTION 7 0.0001
777 HYPERGLYCAEMIA 5 0.0001
778 PANIC ATTACK 5 0.0001
779 UNDERDOSE 10 0.0001
780 DYSPHONIA 8 0.0001
781 ACCIDENTAL OVERDOSE 5 0.0001
782 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
783 CARDIOMYOPATHY 2 0.0001
784 COLON CANCER 2 0.0001
785 THROMBOCYTOPENIA 15 0.0001
786 PULMONARY OEDEMA 6 0.0001
787 ORAL PAIN 3 0.0001
788 MUSCULOSKELETAL PAIN 7 0.0001
789 FATIGUE 104 0.0001
790 PANCREATITIS ACUTE 3 0.0001
791 HYPOAESTHESIA ORAL 2 0.0001
792 DISCOMFORT 8 0.0001
793 EPILEPSY 4 0.0001
794 FEELING HOT 8 0.0001
795 INJECTION SITE RASH 4 0.0001
796 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
797 MUSCULOSKELETAL CHEST PAIN 2 0.0001
798 VISUAL IMPAIRMENT 16 0.0001
799 LUNG INFECTION 2 0.0001
800 EJECTION FRACTION DECREASED 2 0.0001
801 BASAL CELL CARCINOMA 2 0.0001
802 CHILLS 15 0.0001
803 TREATMENT NONCOMPLIANCE 7 0.0001
804 FLUSHING 13 0.0001
805 ARTHRITIS 10 0.0001
806 HAEMATOCHEZIA 7 0.0001
807 NEUROPATHY PERIPHERAL 12 0.0001
808 ARTHROPATHY 7 0.0001
809 ABSCESS 2 0.0001
810 MOBILITY DECREASED 9 0.0001
811 DIABETIC KETOACIDOSIS 3 0.0001
812 MYALGIA 21 0.0001
813 BLOOD POTASSIUM INCREASED 2 0.0001
814 DEVICE BREAKAGE 5 0.0001
815 DYSKINESIA 5 0.0001
816 GASTROINTESTINAL DISORDER 11 0.0001
817 INJECTION SITE URTICARIA 3 0.0001
818 METASTASES TO BONE 2 0.0001
819 INJECTION SITE ERYTHEMA 15 0.0001
820 DRUG LEVEL INCREASED 2 0.0001
821 AGGRESSION 6 0.0001
822 ANXIETY 34 0.0001
823 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
824 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
825 CARDIOVASCULAR DISORDER 3 0.0001
826 DIABETES MELLITUS 9 0.0001
827 NEUTROPENIA 16 0.0001
828 ACUTE KIDNEY INJURY 18 0.0001
829 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
830 HEPATITIS 3 0.0001
831 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
832 IRRITABILITY 7 0.0001
833 DYSPHAGIA 11 0.0001
834 EXPOSURE VIA SKIN CONTACT 3 0.0001
835 MULTI-ORGAN FAILURE 2 0.0001
836 THERAPEUTIC RESPONSE DECREASED 7 0.0001
837 SUICIDE ATTEMPT 7 0.0001
838 STOMATITIS 7 0.0001
839 NEOPLASM PROGRESSION 4 0.0001
840 VERTIGO 7 0.0001
841 JOINT STIFFNESS 3 0.0001
842 ASTHENIA 43 0.0001
843 CONTUSION 11 0.0001
844 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
845 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
846 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
847 ABDOMINAL PAIN UPPER 23 0.0001
848 THROAT IRRITATION 5 0.0001
849 RASH PRURITIC 6 0.0001
850 END STAGE RENAL DISEASE 2 0.0001
851 SKIN IRRITATION 5 0.0001
852 SKIN DISCOLOURATION 5 0.0001
853 HYPERHIDROSIS 14 0.0001
854 DYSURIA 4 0.0001
855 AGRANULOCYTOSIS 2 0.0001
856 RENAL DISORDER 5 0.0001
857 HYPONATRAEMIA 6 0.0001
858 DYSARTHRIA 4 0.0001
859 HALLUCINATION 8 0.0001
860 BLOOD SODIUM DECREASED 2 0.0001
861 RENAL FAILURE 14 0.0001
862 HAEMORRHAGE 11 0.0001
863 INJECTION SITE PAIN 32 0.0001
864 ACUTE RESPIRATORY FAILURE 2 0.0001
865 HERNIA 2 0.0001
866 HYPOGLYCAEMIA 5 0.0001
867 CHOKING 2 0.0001
868 TREMOR 17 0.0001
869 PARAESTHESIA 16 0.0001
870 DYSPEPSIA 10 0.0001
871 URINARY INCONTINENCE 3 0.0001
872 DISABILITY 2 0.0001
873 DEPRESSION 23 0.0001
874 DISORIENTATION 4 0.0001
875 HAEMATOCRIT DECREASED 2 0.0001
876 INJURY 7 0.0001
877 ILL-DEFINED DISORDER 6 0.0001
878 EXTRA DOSE ADMINISTERED 4 0.0001
879 BONE MARROW FAILURE 2 0.0001
880 LUNG NEOPLASM MALIGNANT 4 0.0001
881 EMOTIONAL DISORDER 3 0.0001
882 NERVOUS SYSTEM DISORDER 3 0.0001
883 RESPIRATORY FAILURE 7 0.0001
884 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
885 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
886 NERVOUSNESS 5 0.0001
887 DERMATITIS 2 0.0001
888 ABDOMINAL DISCOMFORT 16 0.0001
889 SEIZURE 11 0.0001
890 PANCREATITIS 5 0.0001
891 RENAL FAILURE ACUTE 4 0.0001
892 LOSS OF CONSCIOUSNESS 12 0.0001
893 HIP FRACTURE 3 0.0001
894 LIVER FUNCTION TEST INCREASED 2 0.0001
895 MUSCULOSKELETAL STIFFNESS 8 0.0001
896 APPLICATION SITE PAIN 2 0.0001
897 SKIN DISORDER 3 0.0001
898 ANGER 3 0.0001
899 HEART RATE IRREGULAR 2 0.0001
900 APPLICATION SITE PRURITUS 2 0.0001
901 INJECTION SITE BRUISING 7 0.0001
902 OFF LABEL USE 76 0.0001
903 MUSCLE TWITCHING 2 0.0001
904 DRY MOUTH 7 0.0001
905 MYOCARDIAL INFARCTION 15 0.0001
906 ARRHYTHMIA 4 0.0001
907 PSORIASIS 11 0.0001
908 THERAPY INTERRUPTED 6 0.0001
909 INCORRECT DOSE ADMINISTERED 19 0.0001
910 DRUG EFFECT INCOMPLETE 3 0.0001
911 MENTAL IMPAIRMENT 2 0.0001
912 PRODUCT QUALITY ISSUE 11 0.0001
913 ABASIA 2 0.0001
914 AGEUSIA 2 0.0001
915 COLITIS 3 0.0001
916 ABDOMINAL PAIN LOWER 2 0.0001
917 CHRONIC KIDNEY DISEASE 6 0.0001
918 OVERDOSE 17 0.0001
919 ADVERSE DRUG REACTION 7 0.0001
920 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
921 HAEMATOMA 2 0.0001
922 DIPLOPIA 2 0.0001
923 AMNESIA 5 0.0001
924 SWELLING FACE 5 0.0001
925 PRODUCT DOSE OMISSION 5 0.0001
926 ALOPECIA 15 0.0001
927 APPLICATION SITE ERYTHEMA 2 0.0001
928 DRUG INTERACTION 12 0.0001
929 BRADYCARDIA 4 0.0001
930 NEOPLASM MALIGNANT 5 0.0001
931 BREAST CANCER FEMALE 2 0.0001
932 SOMNOLENCE 15 0.0001
933 MEMORY IMPAIRMENT 10 0.0001
934 INJECTION SITE REACTION 5 0.0001
935 ABNORMAL DREAMS 2 0.0001
936 MENTAL STATUS CHANGES 2 0.0001
937 FEELING COLD 2 0.0001
938 RECTAL HAEMORRHAGE 3 0.0001
939 ANGINA PECTORIS 2 0.0001
940 HYPOACUSIS 3 0.0001
941 LETHARGY 4 0.0001
942 BALANCE DISORDER 6 0.0001
943 MENTAL DISORDER 3 0.0001
944 DYSSTASIA 2 0.0001
945 AGITATION 5 0.0001
946 ANGIOEDEMA 3 0.0001
947 DYSGEUSIA 5 0.0001
948 COLITIS ULCERATIVE 3 0.0001
949 DEVICE ISSUE 6 0.0001
950 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
951 CORONARY ARTERY DISEASE 2 0.0001
952 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
953 SUICIDAL IDEATION 6 0.0001
954 BREAST CANCER 6 0.0001
955 EXPOSURE DURING PREGNANCY 4 0.0001
956 BONE DENSITY DECREASED 2 0.0001
957 INJECTION SITE HAEMORRHAGE 5 0.0001
958 BLOOD GLUCOSE DECREASED 3 0.0001
959 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
960 DRUG INTOLERANCE 6 0.0001
961 COMPLETED SUICIDE 5 0.0001
962 DISEASE PROGRESSION 7 0.0001
963 THERAPY CESSATION 3 0.0001
964 EMOTIONAL DISTRESS 7 0.0001
965 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
966 DRUG EFFECT DECREASED 3 0.0001
967 DISTURBANCE IN ATTENTION 3 0.0001
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
969 ADVERSE EVENT 5 0.0001
970 UNEVALUABLE EVENT 4 0.0001
971 BONE PAIN 3 0.0001
972 THROMBOSIS 4 0.0000
973 DRUG ABUSE 4 0.0000
974 CEREBROVASCULAR ACCIDENT 8 0.0000
975 DEVICE DISLOCATION 2 0.0000
976 CONFUSIONAL STATE 7 0.0000
977 DEVICE MALFUNCTION 3 0.0000
978 PULMONARY EMBOLISM 4 0.0000
979 DISEASE RECURRENCE 2 0.0000
980 SYNCOPE 4 0.0000
981 ACNE 3 0.0000
982 DEATH 34 0.0000
983 CARDIAC ARREST 3 0.0000
984 DRUG DOSE OMISSION 6 0.0000
985 FLATULENCE 2 0.0000
986 BLOOD GLUCOSE INCREASED 6 0.0000
987 DEVICE DIFFICULT TO USE 2 0.0000
988 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
989 HOSPITALISATION 4 0.0000
990 INTENTIONAL PRODUCT MISUSE 2 0.0000